Literature DB >> 15707998

Cytokeratin 8 associates with the external leaflet of plasma membranes in tumour cells.

Olivier Gires1, Michaela Andratschke, Bärbel Schmitt, Brigitte Mack, Martina Schaffrik.   

Abstract

We reported the identification of tumour-associated antigens from head and neck carcinomas, including cytokeratin 8 (CK8). These antigens were isolated based on the humoral immune response they elicit in vivo using the antibody-mediated identification of antigens technology. Unlike healthy squamous epithelium, tumour cells displayed CK8 at the plasma membrane. However, the actual presence of CK8 at the plasma membrane is still a matter of debate. Here, we have analyzed the expression of CK8 in detail using confocal laser scanning microscopy and circumstantiated its localization at the plasma membrane of carcinoma cells. Healthy human tissues were devoid of CK8 at the membrane, with the exception of hepatocytes. Moreover, membrane-associated CK8 molecules experienced a re-distribution throughout mitosis, which was associated with phosphorylation at serine 73. Phosphorylated CK8 redistributed into dense speckles and relocated to the plasma membrane upon cytokinesis. Thus, CK8 possesses genuine extracellular epitopes on tumour cells, which may represent valuable targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707998     DOI: 10.1016/j.bbrc.2005.01.074

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Surface-affinity profiling to identify host-pathogen interactions.

Authors:  Annemarie Boleij; Coby M Laarakkers; Jolein Gloerich; Dorine W Swinkels; Harold Tjalsma
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

2.  Prostate cancer cell surface-associated keratin 8 and its implications for enhanced plasmin activity.

Authors:  Melissa Hirsch Kuchma; Joo Hee Kim; Mark T Muller; Philip A Arlen
Journal:  Protein J       Date:  2012-03       Impact factor: 2.371

Review 3.  Keratin 1 as a cell-surface receptor in cancer.

Authors:  Oluseye Ogunnigbagbe; Christopher G Bunick; Kamaljit Kaur
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-12-07       Impact factor: 11.414

4.  Identification of proteins with the CDw75 epitope in human colorectal cancer.

Authors:  Óscar Mariño-Crespo; Almudena Fernández-Briera; Emilio Gil-Martín
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

5.  Overexpression of cell surface cytokeratin 8 in multidrug-resistant MCF-7/MX cells enhances cell adhesion to the extracellular matrix.

Authors:  Fang Liu; Zhong Chen; Jinhong Wang; Xiaofeng Shao; Ziyou Cui; Chunzheng Yang; Zhenping Zhu; Dongsheng Xiong
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

6.  Keratin 8 expression in head and neck epithelia.

Authors:  Christoph Matthias; Brigitte Mack; Alexander Berghaus; Olivier Gires
Journal:  BMC Cancer       Date:  2008-09-22       Impact factor: 4.430

Review 7.  From plasminogen to plasmin: role of plasminogen receptors in human cancer.

Authors:  Miroslava Didiasova; Lukasz Wujak; Malgorzata Wygrecka; Dariusz Zakrzewicz
Journal:  Int J Mol Sci       Date:  2014-11-17       Impact factor: 5.923

8.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17

9.  Cytokeratin 8 is an epithelial cell receptor for Pet, a cytotoxic serine protease autotransporter of Enterobacteriaceae.

Authors:  Raul Nava-Acosta; Fernando Navarro-Garcia
Journal:  mBio       Date:  2013-12-10       Impact factor: 7.867

10.  Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.

Authors:  Des C Jones; Colin R A Hewitt; María R López-Álvarez; Martin Jahnke; Alasdair I Russell; Valeria Radjabova; Alice R Z Trowsdale; John Trowsdale
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.